Hyperglycemia is Associated With Increased Mortality in Critically Ill Patients With COVID-19.
Alon Yehuda Mazori,Ilana Bass,Lili Chan,Kusum S. Mathews,Deena R. Altman,Aparna Saha,Howard Soh,Huei Hsun Wen,Sonali Bose,Emily Leven,Jing Gennie Wang,Gohar Mosoyan,Pattharawin Pattharanitima,Giampaolo Greco,Emily J. Gallagher +14 more
33
TL;DR: In this paper, the authors explore the relationship between hyperglycemia in the presence and absence of diabetes mellitus and adverse outcomes in critically ill patients with coronavirus disease 2019 (COVID-19).
read more
About: This article is published in Endocrine Practice. The article was published on 09 Jan 2021. and is currently open access. The article focuses on the topics: End stage renal disease & Retrospective cohort study.
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
Glycemic Management in Patients with COVID-19 Admitted to the Intensive Care Unit: Evaluation of Glycemic Control and Drug Therapy
Emily Blacklaws,Kieran Shah,Sarah Stabler +2 more
TL;DR: Critically ill COVID-19 patients exhibit high incidence of hyperglycemia, impacting outcomes. Clinicians shifted from continuous IV insulin infusions to alternative glycemic management strategies due to resource constraints during the pandemic.
Clinical Characteristics and Prognosis of COVID-19 patients in Syria: A cross-sectional multicenter study
Hasan Nabil Al Houri,Heba Al-Tarcheh,Ebtesam Zahra,Ammar Al-Tarcheh,Humam Armashi,Marwan Alhalabi +5 more
TL;DR: The first case in Syria was reported on March 22, 2020, and this is the first study that aimed to describe the clinical characteristics, comorbidities, and prognosis of COVID-19 patients in Syria as discussed by the authors .
Association between Hyperglycemia at Hospital Presentation and Hospital Outcomes in COVID-19 Patients with and without Type 2 Diabetes: A Retrospective Cohort Study of Hospitalized Inner-City COVID-19 Patients.
TL;DR: In this paper, the authors investigated the relationship among hyperglycemia (HG), the presence of type 2 diabetes (T2D), and the outcomes of COVID-19.
Cardiovascular and renal risk factors and complications associated with COVID-19.
Rhian M. Touyz,Marcus O.E. Boyd,Tomasz J. Guzik,Sandosh Padmanabhan,Linsay McCallum,Christian Delles,Patrick B. Mark,John R. Petrie,Francisco J. Rios,Augusto C. Montezano,Robert Sykes,Colin Berry +11 more
- 16 Jun 2021
TL;DR: In this paper, the authors discuss cardiovascular and kidney disease in the context of COVID-19 and provide recent advances on putative pathophysiological mechanisms linking cardiovascular disease and COVID, focusing on the renin-angiotensin system (RAS) and ACE2 as well as the immune system and inflammation.
References
Intensive Insulin Therapy in Critically Ill Patients
Greet Van den Berghe,Pieter Wouters,Frank Weekers,Charles Verwaest,Frans Bruyninckx,Miet Schetz,Dirk Vlasselaers,Patrick Ferdinande,Peter Lauwers,Roger Bouillon +9 more
TL;DR: Intensive insulin therapy to maintain blood glucose at or below 110 mg per deciliter reduces morbidity and mortality among critically ill patients in the surgical intensive care unit.
9.9K
Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area.
Safiya Richardson,Safiya Richardson,Jamie S. Hirsch,Jamie S. Hirsch,Mangala Narasimhan,James M. Crawford,Thomas McGinn,Thomas McGinn,Karina W. Davidson,Karina W. Davidson,Douglas P. Barnaby,Douglas P. Barnaby,Lance B Becker,John Chelico,John Chelico,Stuart L. Cohen,Stuart L. Cohen,Jennifer Cookingham,Kevin Coppa,Michael A Diefenbach,Andrew J. Dominello,Joan Duer-Hefele,Louise Falzon,Jordan Gitlin,Negin Hajizadeh,Negin Hajizadeh,Tiffany G. Harvin,David Hirschwerk,Eun Ji Kim,Eun Ji Kim,Zachary Kozel,Lyndonna Marrast,Lyndonna Marrast,Jazmin N. Mogavero,Gabrielle A. Osorio,Michael Qiu,Theodoros P. Zanos +36 more
TL;DR: This case series provides characteristics and early outcomes of sequentially hospitalized patients with confirmed COVID-19 in the New York City area and assesses outcomes during hospitalization, such as invasive mechanical ventilation, kidney replacement therapy, and death.
9.7K
Intensive versus conventional glucose control in critically ill patients.
Nice-Sugar Study Investigators,Dean R. Chittock,Steve Su,D. Blair,Denise Foster,Rinaldo Bellomo,Deborah J. Cook,Vinay Dhingra,Peter Dodek,Paul C. Hébert,William R. Henderson,Stephane Heritier,Daren K. Heyland,Colin McArthur,Ellen McDonald,Imogen Mitchell,Robyn Norton,J. Potter,Bruce G. Robinson,Juan J. Ronco +19 more
TL;DR: In this large, international, randomized trial, it was found that intensive glucose control increased mortality among adults in the ICU: a blood glucose target of 180 mg or less per deciliter resulted in lower mortality than did a target of 81 to 108 mg perDeciliter.
Intensive insulin therapy and pentastarch resuscitation in severe sepsis.
Frank M. Brunkhorst,Christoph Engel,Frank Bloos,Andreas Meier-Hellmann,Max Ragaller,Norbert Weiler,Onnen Moerer,Matthias Gruendling,Michael Oppert,Stefan Grond,Derk Olthoff,Ulrich Jaschinski,Stefan John,Rolf Rossaint,Tobias Welte,Martin Schaefer,Peter M. Kern,Evelyn Kuhnt,Michael Kiehntopf,Christiane S. Hartog,Charles Natanson,Markus Loeffler,Konrad Reinhart +22 more
TL;DR: The use of intensive insulin therapy placed critically ill patients with sepsis at increased risk for serious adverse events related to hypoglycemia and HES was harmful, and its toxicity increased with accumulating doses.
Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes : a systematic overview
TL;DR: Stress hyperglycaemia with myocardial infarction is associated with an increased risk of in-hospital mortality in patients with and without diabetes; the risk of congestive heart failure or cardiogenic shock is also increased in patients without diabetes.
2.3K